Articles

Find an Article

Filter articles

Applied Filters

Showing 11 to 20 of 39 results

LSIPR 50 2018: Naoko Munakata

Japan30-07-2018

Naoko Munakata was selected in the LSIPR 50 2018 publication for​ ​her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Raymond Chen and Kathleen O’Malley

US20-07-2018

Raymond Chen and Kathleen O’Malley were selected in the LSIPR 50 2018 publication for​ ​their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Backing the innovators

US17-07-2018

Josh Makower, partner at venture capital investor New Enterprise Associates, explains to LSIPR the firm’s role in supporting medtech innovation, his sweet spot when it comes to projects, and how to balance what is medically relevant with commercial viability.

LSIPR 50 2018: At the head of an experiment in innovation

France09-07-2018

Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR.

Medicines regulation after Brexit: compromise the key

EU04-06-2018

With Brexit looming, questions are being asked about the future regulatory relationship between the EU and the UK, with life sciences companies wondering how they will be affected. LSIPR reports.

LSIPR 50 2017: Leda Trivinos—Playing the long game

US10-11-2017

Thinking about how IP can assist a company long before it has fully developed is essential, says Leda Trivinos of Flagship Pioneering in an interview with LSIPR.

LSIPR 50 2017: Anthony Atala—Surgeon by day, researcher by night

US10-11-2017

Anthony Atala combines the roles of surgeon and researcher in regenerative medicine, allowing him to stay mindful of why his work is important. He talks to LSIPR about his twin professions.

LSIPR 50 2017: Mike Young

US10-11-2017

Mike Young was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

Stem cells in Costa Rica: a boost for medical research

Costa Rica04-07-2017

Now that Costa Rica has allowed adult stem cells to be used as part of regenerative therapies, the country should be able to attract more investment, say María del Pilar López and Esteban Monge of Zürcher Lawyers.

Navigating medical use in Japan

Japan21-06-2017

A handful of high-profile disputes over medical use patents have been decided in Japan, as Osamu Yamamoto of Yuasa and Hara reports.

Showing 11 to 20 of 39 results

LSIPR